NAMI
Jinxin Technology Holding Company American Depositary Shares
There isn't enough reported data to score NAMI yet.
RDDT
Reddit, Inc.
RDDT's fundamentals are strong: revenue grew 62% and its operating margin rose 16 points to 29%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
NAMI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
NAMI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
RDDT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
RDDT's revenue, profitability, cash flow and balance sheet are all currently healthy.
NAMI PE Valuation
NAMI has no meaningful PE right now: it lost money over the past year.
RDDT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $99.55 | — |
| Current | 20x | $99.55 | — |
| Cheap | 35x | $171 | +72% |
| Fair | 46x | $228 | +129% |
| Expensive | 53x | $262 | +163% |
Historical ranges are pointers, not guarantees.
RDDT's PE is 20x, but its earnings don't support one, so it isn't a reliable read right now.
NAMI Forward outlook
There aren't enough analyst estimates for NAMI to show an outlook.
RDDT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for RDDT, with profitability improving. However, they disagree widely on these estimates.
NAMI Earnings Per Share
NAMI and RDDT do not have enough comparable growth data to identify a winner.
RDDT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.32 | +29% |
| Q3 2024 | -$7.98 | -$7.17 |
| Q2 2024 | -$8.19 | -$7.15 |
| Q1 2024 | -$8.38 | -$7.25 |
| Q4 2023 | -$0.56 | +$0.41 |
| Q3 2023 | -$0.81 | -$0.02 |
| Q2 2023 | -$1.04 | -$0.48 |
| Q1 2023 | -$1.13 | -$0.48 |
| Q4 2022 | -$0.97 | -$0.19 |
RDDT has returned to profit: it earned $4.90 per share over the past year, after losing money the year before.
NAMI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $21.4M | -32% |
| Q4 2025 | $30.7M | -1.9% |
| Q2 2025 | $31.3M | +5.3% |
| Q4 2024 | $31.3M | -0.7% |
| Q2 2024 | $29.7M | +17% |
RDDT has the edge over NAMI in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -10% | -26 points |
| Q4 2025 | -39% | -60 points |
| Q2 2025 | -11% | -33 points |
| Q4 2024 | -2.3% | N/A |
| Q2 2024 | 16% | N/A |
| Q4 2023 | 21% | N/A |
| Q2 2023 | 22% | N/A |
NAMI's operating margin was −10% last quarter, down 26 points from the same quarter a year ago.
RDDT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $895M | +53% |
| Q2 2026 | $804.9M | +61% |
| Q1 2026 | $663.4M | +69% |
| Q4 2025 | $725.6M | +70% |
| Q3 2025 | $584.9M | +68% |
| Q2 2025 | $499.6M | +78% |
| Q1 2025 | $392.4M | +61% |
| Q4 2024 | $427.7M | +71% |
RDDT has the edge over NAMI in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +5.5 points |
| Q2 2026 | 29% | +15 points |
| Q1 2026 | 28% | +27 points |
| Q4 2025 | 32% | +20 points |
| Q3 2025 | 24% | +22 points |
| Q2 2025 | 14% | +25 points |
| Q1 2025 | 1% | +244 points |
| Q4 2024 | 12% | +11 points |
RDDT has the edge over NAMI on profitability, with a higher operating margin.
NAMI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$413.5K | -137% |
| Q4 2025 | -$4.9M | -810% |
| Q2 2025 | $1.1M | -63% |
| Q4 2024 | $693K | -76% |
| Q2 2024 | $3M | -46% |
NAMI and RDDT do not have enough comparable growth data to identify a winner.
RDDT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $362.6M | +98% |
| Q2 2026 | $260.7M | +135% |
| Q1 2026 | $311.2M | +146% |
| Q4 2025 | $263.6M | +196% |
| Q3 2025 | $183.1M | +161% |
| Q2 2025 | $110.8M | +308% |
| Q1 2025 | $126.6M | +333% |
| Q4 2024 | $89.2M | +$111.2M |
RDDT generated $1.2B in free cash flow over the past year, up 135% from the year before.
NAMI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.1% | +2M shares |
| 1 year | +93% | +24.2M shares |
NAMI has 50M diluted shares, up 93% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $7,524 |
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | — |
| Q2 2023 | — |
RDDT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -169K shares |
| 1 year | -0.4% | -868K shares |
| 3 years | +24% | +38.5M shares |
| 5 years | +24% | +38.5M shares |
RDDT has the edge over NAMI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100.4M |
| Q2 2026 | $234.6M |
| Q1 2026 | $5M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $4.2M |
| Q4 2022 | — |
NAMI Net Leverage
NAMI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RDDT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.5x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -3.3x | Net Cash |
| Q2 2025 | -5.0x | Net Cash |
| Q1 2025 | -13.1x | Net Cash |
RDDT has more cash than debt.
NAMI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.0 | Neutral |
| Stochastic | 3.9 | Oversold |
NAMI's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
RDDT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.8 | Neutral |
| Stochastic | 6.5 | Oversold |
RDDT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
NAMI PE vs Communication Services Sector
NAMI has no meaningful PE right now: it lost money over the past year.
RDDT PE vs Communication Services Sector
| Metric | RDDT | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 16x | 23% above |
| PE % | 5 | 23 | 18 pts below |
RDDT is trading at 20x earnings, a 23% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
NAMI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.86 | 13% below |
| 20 week MA | $2.50 | 35% below |
| 50 week MA | $8.83 | 82% below |
| 100 week MA | $30.2 | 95% below |
NAMI and RDDT share similar trend alignment, each above 0 of 4 tracked weekly averages.
RDDT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $130.6 | 24% below |
| 20 week MA | $151.7 | 34% below |
| 50 week MA | $165.0 | 40% below |
| 100 week MA | $167.1 | 40% below |
RDDT is in a downtrend: it's below all four of its weekly moving averages, and 40% below its 100-week average.
NAMI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $111.0 | $104.5 | -5.9% |
| 2025 | $104.5 | $18.4 | -82% |
| 2026 YTD | $18.4 | $1.62 | -91% |
NAMI has finished every year since 2024 lower, and it's down 91% so far in 2026.
RDDT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $46.0 | $173.5 | +277% |
| 2025 | $173.5 | $225.8 | +30% |
| 2026 YTD | $225.8 | $99.6 | -56% |
RDDT has the edge over NAMI on returns for 2026, with the stronger performance.